Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Eculizumab
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Eculizumab
Nutrition and blood, Drugs used in hypoplastic, haemolytic, and renal anaemias and in sickle cell disease, 09.01.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Eculizumab
Eculizumab
Blood And Blood-Forming Organs, Anaemias, Hypoplastic, Haemolytic, And Renal Anaemias, Immunosuppressants Complement Inhibitors
Eculizumab
Eculizumab
Immune System, Immune System Disorders And Transplantation, Immunosuppressants Complement Inhibitors
Eculizumab
Eculizumab
Musculoskeletal System, Neuromuscular Disorders, Myasthenia Gravis And Lambert-Eaton Myasthenic Syndrome, Immunosuppressants Complement Inhibitors
Links found
Clinical Commissioning Policy; Rituximab and eculizumab for the prevention and management of delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies [URN 1821] [200602P]
NICE TA1010: Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuria